Braun-Bostich & Associates’s Labcorp LH Stock Holding History

Braun-Bostich & Associates’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-47	Closed	-$5K	–	334
2018 Q4	$5K	Hold	47	–	–	0.01%	286
2018 Q3	$7K	Buy	+47	New	+$7.15K	0.01%	282

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Braun-Bostich & Associates's LH Position: Q1 2019 in Review

Braun-Bostich & Associates sold out of Labcorp (LH) in Q1 2019, closing a stake of 47 shares — an estimated $5K sold.

Braun-Bostich & Associates first reported a position in LH in Q3 2018 and held it in 2 quarters. The position peaked at $7K in Q3 2018. 744 funds tracked by Wall St. Rank hold LH as of Q1 2019.

Braun-Bostich & Associates reported no remaining Labcorp position as of Q1 2019 after selling out during the quarter.
Braun-Bostich & Associates sold 47 Labcorp shares in Q1 2019, an estimated $5K.
Braun-Bostich & Associates first reported a position in Labcorp in Q3 2018 and held it in 2 quarters.
Braun-Bostich & Associates's Labcorp position peaked at $7K in Q3 2018.
744 funds tracked by Wall St. Rank held Labcorp as of Q1 2019.

Based on Braun-Bostich & Associates's 13F filing for Q1 2019, filed 9 May 2019.